4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- manufacturers
- TP-238
-
- $1520.00
-
2026-05-11
- CAS:2415263-04-4
- Purity:
- Supply Ability: 10g
|
| | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- Basic information |
| | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- Chemical Properties |
| Boiling point | 702.0±70.0 °C(Predicted) | | density | 1.25±0.1 g/cm3(Predicted) | | pka | 9.25±0.28(Predicted) |
| | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- Usage And Synthesis |
| Uses | TP-238 is a potent and selective dual CECR2/BPTF probe with IC50 values of 30 nM and 350 nM, respectively. TP-238 also inhibits BRD9 with a pIC50 of 5.9 and is less active against other 338 kinases[1][2]. | | IC 50 | CECR2: 30 nM (IC50); CECR2: 10 nM (Kd); CECR2: 7.5 (pIC50); BPTF: 350 nM (IC50); BPTF: 120 nM (Kd); BPTF: 6.5 (pIC50); BRD9: 5.9 (pIC50) | | References | [1] Michael A Clegg, et al. Advancements in the Development of non-BET Bromodomain Chemical Probes. ChemMedChem. 2019 Feb 19;14(4):362-385. DOI:10.1002/cmdc.201800738 [2] Peter D Ycas, et al. New Inhibitors for the BPTF Bromodomain Enabled by Structural Biology and Biophysical Assay Development. Org Biomol Chem. 2020 Jun 26. DOI:10.1039/d0ob00506a |
| | 4-Pyrimidinamine, 6-[4-[3-(dimethylamino)propoxy]phenyl]-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]- Preparation Products And Raw materials |
|